[1] |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018[J]. CA: A Cancer J Clin, 2018, 68(1): 7-30.
doi: 10.3322/caac.v68.1
URL
|
[2] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.
doi: 10.3322/caac.v68.6
URL
|
[3] |
Ng JH, Iyer NG, Tan MH, et al. Changing epidemiology of oral squamous cell carcinoma of the tongue: a global study[J]. Head Neck, 2017, 39(2): 297-304.
doi: 10.1002/hed.v39.2
URL
|
[4] |
Semenza GL. Signal transduction to hypoxia-inducible factor 1[J]. Biochem Pharmacol, 2002, 64(5-6): 993-998.
doi: 10.1016/s0006-2952(02)01168-1
pmid: 12213597
|
[5] |
李继强, 陈谦学. 缺氧诱导因子1α相关信号通路与肿瘤关系的研究进展[J]. 医学综述, 2015, 21(24): 4460-4464.
|
[6] |
李力军, 叶家欣, 唐忠志, 等. miR-210对急性心肌梗死早期的诊断价值[J]. 中西医结合心脑血管病杂志, 2019, 17(18): 2819-2822.
|
[7] |
李艳丽, 宋琛, 李冬静, 等. 检测血清miR-181b、miR-210诊断妊娠期高血压疾病价值[J]. 中国计划生育学杂志, 2019, 27(9): 1217-1220.
|
[8] |
王俊钢, 李聪聪, 毛广显, 等. MiR-210调控Mex3B蛋白对肺癌细胞侵袭和增殖的影响[J]. 中国免疫学杂志, 2017, 33(10): 1468-1473.
|
[9] |
蓝永洪, 牛海艳, 王晗, 等. MiR-210对乳腺癌细胞生物学行为的影响[J]. 安徽医科大学学报, 2017, 52(1): 83-85.
|
[10] |
曹治云, 张志灯, 陈旭征, 等. 低氧条件下低氧诱导因子1α/miR-210调节回路对肿瘤能量代谢及血管生成的调控[J]. 中华细胞与干细胞杂志(电子版), 2016, 6(3): 195-198.
|
[11] |
Lin ZY, Sun LJ, Chen WL, et al. MiR-639 regulates transforming growth factor beta-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting FOXC1[J]. Cancer Sci, 2014, 105(10): 1288-1298.
doi: 10.1111/cas.2014.105.issue-10
URL
|
[12] |
Guo Y, Qiao X, Zhu L, et al. MiR-182-5p modulates oral squamous cell carcinoma migration and invasion via targeting MTSS1 gene[J]. Pathol Oncol Res, 2020, 26(2): 1007-1013.
doi: 10.1007/s12253-019-00647-8
|
[13] |
肖洒, 蔡宙, 钟欣超, 等. 血清miR-210和miR-375在非小细胞肺癌患者中的表达变化情况[J]. 国际检验医学杂志, 2019, 40(2): 156-161.
|
[14] |
王冰, 徐臻, 赵虎, 等. 卵巢癌患者血清miR-210、miR-126与临床病理特征及预后关系探讨[J]. 中国计划生育学杂志, 2019, 27(2): 221-225, 229.
|
[15] |
Scapoli L, Palmieri A, Lo Muzio L, et al. MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression[J]. Int J Immunopathol Pharmacol, 2010, 23(4): 1229-1234.
doi: 10.1177/039463201002300427
pmid: 21244772
|
[16] |
Lu Y, Li Y, Wang Z, et al. Downregulation of RGMA by HIF-1A/miR-210-3p axis promotes cell proliferation in oral squamous cell carcinoma[J]. Biomedecine Pharmacother, 2019, 112: 108608.
|
[17] |
Xu TX, Zhao SZ, Dong M, et al. Hypoxia responsive miR-210 promotes cell survival and autophagy of endometriotic cells in hypoxia[J]. Eur Rev Med Pharmacol Sci, 2016, 20(3): 399-406.
|
[18] |
Melo SA, Esteller M. Dysregulation of microRNAs in cancer: playing with fire[J]. FEBS Lett, 2011, 585(13): 2087-2099.
doi: 10.1016/j.febslet.2010.08.009
pmid: 20708002
|
[19] |
Wang Z, Deng M, Liu Z, et al. Hypoxia-induced miR-210 promoter demethylation enhances proliferation, autophagy and angiogenesis of schwannoma cells[J]. Oncol Rep, 2017, 37(5): 3010-3018.
doi: 10.3892/or.2017.5511
pmid: 28440459
|